Delivery Order SPE2DB22D3019-SPE2DB25FK3UD
Award Date
6/11/25
Potential Completion Date
6/12/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of QUVIVIQ 25 MG TABLET 30S. The contract has a firm fixed price of $1,027.28 and a performance period through June 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,841.22 and is for the supply of 4,568,200,528 units of the pharmaceutical product QUVIVIQ 25 MG TABLET 30S. The contract is a firm fixed-price delivery order, with a completion date of May 12, 2025. This contract is not set aside and represents open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,692.28 Delivery Order contract is for the supply of the medication QUVIVIQ 50 MG TABLET 30S, with a period of performance through November 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,516.74 Firm Fixed Price Delivery Order is for the supply of the prescription medication QUVIVIQ 25 MG TABLET 30S, with a completion date of June 21, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,528.80, is for the delivery of QUVIVIQ 50 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen Drug Corp is a large, for-profit pharmaceutical distribution company that plays a critical role in supplying medical...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,601.86, is for the delivery of QUVIVIQ 25 MG TABLET 30S, a prescription medication. The contract is a Firm Fixed Price (FFP) arrangement with a completion date of May 29, 2025. AmerisourceBergen Drug Corp is the prime contractor for this award, which is not set-aside. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,053.91, is a delivery order for the supply of QUVIVIQ 25 MG TABLET 30S, which are pharmaceutical products. The contract has an ultimate completion date of March 6, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of QUVIVIQ 50 MG TABLET 30S, a prescription drug, with a ceiling value of $5,212.24 and a completion date of October 9, 2024. The contract is a firm-fixed-price delivery order, which means AmerisourceBergen will provide the specified pharmaceutical product at a predetermined price. This contract is not...
This federal contract award, with an ID of SPE2DB20D1109|SPE2DB24FP79E, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,238.99, is for the delivery of 4565592630 QUVIVIQ 25 MG TABLET 30S. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of August 28, 2024. Amerisourcebergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Quviviq 50 mg tablets, a medication used for the treatment of insomnia. The contract has a ceiling value of $1,285.96 and a period of performance ending on May 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...